company insight

Lonza Pharma & Biotech – Capsule Delivery Solutions

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally.

SHL Group details its approach to the challenges of emerging formulations

For more than 100 years, biopharmaceutical companies have relied on the quality, consistency and functional innovations Capsugel® has delivered; today we produces more than 200 billion capsules in over 100 countries.

Building on our history of innovation in polymer science and capsule engineering, Capsule Delivery Solutions continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery. Whether you’re looking to formulate new products or enhance an existing line, we have the right capsule to help you bring improved products to market faster. With a diverse portfolio including HPMC, Dry Powder Inhalation capsules or specialized clinical capsules, we are a global leader in capsule development and manufacturing, bringing unmatched products and technical support to our worldwide customer base.

Capsule Delivery Solutions Quality 

From the purchase of key raw materials to the manufacturing, packaging and delivering of finished products, Capsule Delivery Solutions works to ensure the safety and quality of capsules we supply to pharmaceutical customers around the world.

As key elements of our quality commitment, Capsugel is investing in Regulatory Compliance Monitoring Programs that anticipates and proactively responds to the continuously evolving global food-safety standards and maintains a robust Quality System, from sourcing of our ingredients to the distribution of our products, that is compliant with all applicable standards.

Capsule Delivery Solutions offers

High quality empty capsules:

  • Immediate release: Coni-Snap® Gelatin, Vcaps® Plus, Plantcaps®
  • Targeted & Modified release: Vcaps® Enteric, DUOCAP®

  • Dry Powder Inhalation capsules: Gelatin: Coni-Snap® Gelatin and Coni-Snap® Gelatin-PEG, HPMC: Vcaps® and Vcaps® Plus

  • Preclinical and clinical development capsules: PCcaps®, DBcaps®

  • Patient Centric capsules: Coni-Snap® Sprinkle
  • Life Cycle Management solutions: Press-Fit®, XPress-Fit®

Innovative and tailored services:

Share this article

Go to article: Home | Data DrivenGo to article: BrooksGo to article: EditorialGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: LaudaGo to article: NewsGo to article: Fisher Clinical ServicesGo to article: Fisher Clinical Services Company InsightGo to article: The pharma industry briefingGo to article: EcocoolGo to article: Roundtable: experts share their thoughts on Brexit’s impact on clinical trialsGo to article: Cryo StoreGo to article: Opening up the Chinese drug marketGo to article: DelSiTechGo to article: Boosting biosimilar uptake in the US: what needs to change.Go to article: PharmasolGo to article: TriNetX: Using real-world data to improve clinical research Go to article: SmartCAEGo to article: SmartCAE Company InsightGo to article: Unlocking cell-free protein synthesis: biotech’s next big ticketGo to article: Capsugel Company InsightGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: AlpexGo to article: Curing hepatitis C at a fraction of the costGo to article: ILC Dover IncGo to article: Why artificial intelligence and pharmaceuticals are a perfect matchGo to article: Material Flow SolutionsGo to article: Material Flow Solutions Company InsightGo to article: Shaky foundations: the flaws in animal research reportingGo to article: Global Freight Solutions LtdGo to article: Paying the bill for innovative gene and cell therapies Go to article: CBDepotGo to article: CBDepot Company InsightGo to article: EventsGo to article: Bea TechnologiesGo to article: Next issueGo to article: Event: CPhI KoreaGo to article: Syne Qua Non Ltd